FRANCOIS CEDRIC (Chief Executive Officer) reported 2 transactions at APELLIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/13/2026ACC: 0001193125-26-106090
DirectorOfficer· Chief Executive Officer
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
64.87K acquired · 64.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−64.87K
Price / share
—
Trade value
—
% of position
13.2%
3/11/2026
490.84K→425.97K
Common Stock
Indirect
Shares
+64.87K
Price / share
—
Trade value
—
% of position
21.1%
3/11/2026
307.95K→372.81K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | G · Gift | −64.87K | — | — | 13.2% | 490.84K | 425.97K |
| Common Stock Indirect | 3/11/2026 | G · Gift | +64.87K | — | — | 21.1% | 307.95K | 372.81K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned472.06K
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned234.41K
Total
1.01M indirect1.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 472.06K | Indirect |
| Common Stock | 300K | Indirect |
| Common Stock | 234.41K | Indirect |
| Total | 1.01M | 1.01M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported